468 related articles for article (PubMed ID: 16407588)
41. A theoretical study of lipid accumulation in the liver-implications for nonalcoholic fatty liver disease.
Schleicher J; Guthke R; Dahmen U; Dirsch O; Holzhuetter HG; Schuster S
Biochim Biophys Acta; 2014 Jan; 1841(1):62-9. PubMed ID: 23999488
[TBL] [Abstract][Full Text] [Related]
42. [Fatty acid composition of triglycerides in inflammatory liver diseases in diabetics with and without hyperlipoproteinemia].
Singer P; Honigmann G; Schliack V
Z Gesamte Inn Med; 1981 Aug; 36(15):513-9. PubMed ID: 7293284
[TBL] [Abstract][Full Text] [Related]
43. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
44. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.
Pessayre D; Mansouri A; Fromenty B
Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G193-9. PubMed ID: 11804839
[TBL] [Abstract][Full Text] [Related]
45. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
46. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
Ricchi M; Odoardi MR; Carulli L; Anzivino C; Ballestri S; Pinetti A; Fantoni LI; Marra F; Bertolotti M; Banni S; Lonardo A; Carulli N; Loria P
J Gastroenterol Hepatol; 2009 May; 24(5):830-40. PubMed ID: 19207680
[TBL] [Abstract][Full Text] [Related]
47. A human hepatocellular in vitro model to investigate steatosis.
Gómez-Lechón MJ; Donato MT; Martínez-Romero A; Jiménez N; Castell JV; O'Connor JE
Chem Biol Interact; 2007 Jan; 165(2):106-16. PubMed ID: 17188672
[TBL] [Abstract][Full Text] [Related]
48. Nonalcoholic fatty liver disease and the metabolic syndrome.
Marchesini G; Babini M
Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
[TBL] [Abstract][Full Text] [Related]
49. Abnormalities of lipid metabolism in nonalcoholic fatty liver disease.
Cheung O; Sanyal AJ
Semin Liver Dis; 2008 Nov; 28(4):351-9. PubMed ID: 18956291
[TBL] [Abstract][Full Text] [Related]
50. [Patomechanisms of hepatic steatosis].
Fülöp P; Paragh G
Orv Hetil; 2010 Feb; 151(9):323-9. PubMed ID: 20159747
[TBL] [Abstract][Full Text] [Related]
51. Impairment of hepatic microcirculation in fatty liver.
Ijaz S; Yang W; Winslet MC; Seifalian AM
Microcirculation; 2003 Dec; 10(6):447-56. PubMed ID: 14745457
[TBL] [Abstract][Full Text] [Related]
52. Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis.
Stremmel W; Staffer S; Wannhoff A; Pathil A; Chamulitrat W
FASEB J; 2014 Jul; 28(7):3159-70. PubMed ID: 24719358
[TBL] [Abstract][Full Text] [Related]
53. Lipid metabolism during lactation: a review of adipose tissue-liver interactions and the development of fatty liver.
Vernon RG
J Dairy Res; 2005 Nov; 72(4):460-9. PubMed ID: 16223462
[TBL] [Abstract][Full Text] [Related]
54. Relation of steatosis to cirrhosis.
Thaler H
Clin Gastroenterol; 1975 May; 4(2):273-80. PubMed ID: 1126047
[TBL] [Abstract][Full Text] [Related]
55. Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis.
Angrish MM; Kaiser JP; McQueen CA; Chorley BN
Toxicol Sci; 2016 Apr; 150(2):261-8. PubMed ID: 26980302
[TBL] [Abstract][Full Text] [Related]
56. [Changes in fatty metabolism in patients with liver cirrhosis].
Minemura M; Watanabe A
Nihon Rinsho; 2001 Mar; 59 Suppl 3():190-4. PubMed ID: 11347056
[No Abstract] [Full Text] [Related]
57. Endoplasmic reticulum proteostasis in hepatic steatosis.
Baiceanu A; Mesdom P; Lagouge M; Foufelle F
Nat Rev Endocrinol; 2016 Dec; 12(12):710-722. PubMed ID: 27516341
[TBL] [Abstract][Full Text] [Related]
58. Increased hepatocellular uptake of long chain fatty acids occurs by different mechanisms in fatty livers due to obesity or excess ethanol use, contributing to development of steatohepatitis in both settings.
Berk PD; Zhou S; Bradbury MW
Trans Am Clin Climatol Assoc; 2005; 116():335-44; discussion 345. PubMed ID: 16555625
[TBL] [Abstract][Full Text] [Related]
59. Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic.
Bass NM
Hepatology; 2010 Jan; 51(1):4-7. PubMed ID: 20034031
[No Abstract] [Full Text] [Related]
60. [Steatohepatitis and metabolic and nutritional abnormalities].
Deugnier Y; Lainé F
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B9-12. PubMed ID: 12843931
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
